Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").

Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ.

Am J Surg Pathol. 2008 Jan;32(1):36-44.

PMID:
18162768
2.

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT.

Oncogene. 2007 May 31;26(26):3846-56. Epub 2006 Dec 11.

PMID:
17160014
3.

Morphological characterization of the breast in Proteus syndrome complicated by ductal carcinoma in situ.

Iqbal J, He G, Biesecker LG, Rosen P, Duray PH, Schwartzentruber D, Beg M, Kahn E.

Ann Clin Lab Sci. 2006 Autumn;36(4):469-74.

PMID:
17127737
4.

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.

Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW.

Br J Dermatol. 2006 Nov;155(5):988-93.

5.

The effects of gp100 and tyrosinase peptide vaccinations on nevi in melanoma patients.

Cassarino DS, Miller WJ, Auerbach A, Yang A, Sherry R, Duray PH.

J Cutan Pathol. 2006 May;33(5):335-42.

PMID:
16640539
6.

Gene expression profiling of human sarcomas: insights into sarcoma biology.

Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, Glatfelter AA, Duray PH, Meltzer PS.

Cancer Res. 2005 Oct 15;65(20):9226-35.

7.

Molecular alterations in primary prostate cancer after androgen ablation therapy.

Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6823-34.

8.

Invasion of human tissue ex vivo by Borrelia burgdorferi.

Duray PH, Yin SR, Ito Y, Bezrukov L, Cox C, Cho MS, Fitzgerald W, Dorward D, Zimmerberg J, Margolis L.

J Infect Dis. 2005 May 15;191(10):1747-54. Epub 2005 Apr 6.

PMID:
15838803
9.

Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.

Beaty MW, Quezado M, Sobel ME, Duray P, Merino MJ.

Int J Surg Pathol. 2005 Jan;13(1):9-18.

PMID:
15735850
10.

Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.

Figg WD, Franks ME, Venzon D, Duray P, Cox MC, Linehan WM, Van Bingham W, Eastham JA, Reed E, Sartor O.

World J Urol. 2004 Dec;22(6):425-30. Epub 2004 Dec 8.

PMID:
15592675
11.

Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.

Walker GJ, Indsto JO, Sood R, Faruque MU, Hu P, Pollock PM, Duray P, Holland EA, Brown K, Kefford RF, Trent JM, Mann GJ, Hayward NK.

Genes Chromosomes Cancer. 2004 Sep;41(1):56-64.

PMID:
15236317
12.

Immunohistochemistry of normal human knee synovium: a quantitative study.

Singh JA, Arayssi T, Duray P, Schumacher HR.

Ann Rheum Dis. 2004 Jul;63(7):785-90.

13.

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.

Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS.

Oncogene. 2004 Mar 18;23(12):2264-74.

PMID:
14755246
14.

Metastatic nevoid melanoma in a 4 1/2-year-old child.

Cassarino DS, Fullen DR, Sondak VK, Duray PH.

J Cutan Pathol. 2003 Nov;30(10):647-51.

PMID:
14744091
15.

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.

Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, Greene MH, Maslansky B, Fischbein A, Gruber SB, Rennert G, Ronchetti RD, Hewitt SM, Struewing JP, Iscovich J.

J Med Genet. 2003 Oct;40(10):787-92. No abstract available. Erratum in: J Med Genet. 2004 Jan;41(1):51.

16.

Lyme-associated parkinsonism: a neuropathologic case study and review of the literature.

Cassarino DS, Quezado MM, Ghatak NR, Duray PH.

Arch Pathol Lab Med. 2003 Sep;127(9):1204-6. Review.

PMID:
12946221
17.

Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?

Prieto VG, Argenyi ZB, Barnhill RL, Duray PH, Elenitsas R, From L, Guitart J, Horenstein MG, Ming ME, Piepkorn MW, Rabkin MS, Reed JA, Selim MA, Trotter MJ, Johnson MM, Shea CR.

Am J Clin Pathol. 2003 Aug;120(2):203-8.

PMID:
12931550
18.

A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.

Hamilton M, Dahut W, Brawley O, Davis P, Wells-Jones T, Kohler D, Duray P, Liewehr DJ, Lakhani N, Steinberg SM, Figg WD, Reed E.

Acta Oncol. 2003;42(3):195-201.

PMID:
12852695
19.

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.

Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7. Epub 2003 Jun 25.

20.

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.

Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B.

Am J Hum Genet. 2003 Jul;73(1):95-106. Epub 2003 May 22.

21.

Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis.

Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR.

Diagn Mol Pathol. 2003 Jun;12(2):63-70.

PMID:
12766610
22.

Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications.

Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR.

Proteomics. 2003 Apr;3(4):413-21.

PMID:
12687609
23.
24.

Facial papules, spontaneous pneumothorax, and renal tumors.

Toro JR, Glenn G, Hou L, Duray P, Clark B, Merino M, Zbar B, Linehan M, Turner ML.

J Am Acad Dermatol. 2003 Jan;48(1):111-4. No abstract available.

PMID:
12522379
25.

PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers.

Iavarone C, Wolfgang C, Kumar V, Duray P, Willingham M, Pastan I, Bera TK.

Mol Cancer Ther. 2002 Mar;1(5):329-35.

26.
27.

High frequency of BRAF mutations in nevi.

Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS.

Nat Genet. 2003 Jan;33(1):19-20. Epub 2002 Nov 25.

PMID:
12447372
28.

Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.

Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Lindner G, De Fabo EC, DePinho RA, Merlino G.

Cancer Res. 2002 Nov 15;62(22):6724-30.

29.

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA.

Science. 2002 Oct 25;298(5594):850-4. Epub 2002 Sep 19.

30.

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.

Cancer Cell. 2002 Aug;2(2):157-64.

31.

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, Zhao Y, Simon R, Powell JI, Asaki E, Alexander HR, Duray PH, Herlyn M, Restifo NP, Liu ET, Rosenberg SA, Marincola FM.

Cancer Res. 2002 Jul 1;62(13):3581-6.

32.

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.

Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM.

Cancer Cell. 2002 Apr;1(3):279-88.

33.

Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques.

Schrump DS, Zhai S, Nguyen DM, Weiser TS, Fisher BA, Terrill RE, Flynn BM, Duray PH, Figg WD.

J Thorac Cardiovasc Surg. 2002 Apr;123(4):686-94.

34.

Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.

Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, Duray P, Gabril F, Greenberg C, Merino MJ, Toro J, Linehan WM.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393-400.

35.

PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach.

Bera TK, Maitra R, Iavarone C, Salvatore G, Kumar V, Vincent JJ, Sathyanarayana BK, Duray P, Lee BK, Pastan I.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3058-63.

36.

Subcellular localization of trifluoroacetylated liver proteins in association with hepatitis following isoflurane.

Njoku DB, Shrestha S, Soloway R, Duray PR, Tsokos M, Abu-Asab MS, Pohl LR, West AB.

Anesthesiology. 2002 Mar;96(3):757-61. No abstract available.

PMID:
11873055
37.

Evaluation of non-formalin tissue fixation for molecular profiling studies.

Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR.

Am J Pathol. 2002 Feb;160(2):449-57.

38.

Proteomic analysis of human prostate cancer.

Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR.

Mol Carcinog. 2002 Jan;33(1):9-15.

PMID:
11807953
39.

Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer.

Swalwell JI, Vocke CD, Yang Y, Walker JR, Grouse L, Myers SH, Gillespie JW, Bostwick DG, Duray PH, Linehan WM, Emmert-Buck MR.

Genes Chromosomes Cancer. 2002 Feb;33(2):201-5.

PMID:
11793446
40.

Approaches to preclinical screening of antiangiogenic agents.

Kruger EA, Duray PH, Price DK, Pluda JM, Figg WD.

Semin Oncol. 2001 Dec;28(6):570-6. Review.

PMID:
11740811
41.

Neonatal sunburn and melanoma in mice.

Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G.

Nature. 2001 Sep 20;413(6853):271-2.

PMID:
11565020
42.

GDEP, a new gene differentially expressed in normal prostate and prostate cancer.

Olsson P, Bera TK, Essand M, Kumar V, Duray P, Vincent J, Lee B, Pastan I.

Prostate. 2001 Sep 15;48(4):231-41.

PMID:
11536302
43.

Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2.

Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, Pavlovich CP, Glenn G, Greenberg CR, Linehan WM, Zbar B.

Am J Hum Genet. 2001 Oct;69(4):876-82. Epub 2001 Aug 30.

44.

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

Figg WD, Dahut W, Duray P, Hamilton M, Tompkins A, Steinberg SM, Jones E, Premkumar A, Linehan WM, Floeter MK, Chen CC, Dixon S, Kohler DR, Krüger EA, Gubish E, Pluda JM, Reed E.

Clin Cancer Res. 2001 Jul;7(7):1888-93.

45.

PRAC: A novel small nuclear protein that is specifically expressed in human prostate and colon.

Liu XF, Olsson P, Wolfgang CD, Bera TK, Duray P, Lee B, Pastan I.

Prostate. 2001 May 1;47(2):125-31.

PMID:
11340635
46.

Molecular profiling of clinical tissues specimens: feasibility and applications.

Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prang C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH.

J Mol Diagn. 2000 May;2(2):60-6. Review. No abstract available.

47.

Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.

Ornstein DK, Cinquanta M, Weiler S, Duray PH, Emmert-Buck MR, Vocke CD, Linehan WM, Ferretti JA.

J Urol. 2001 Apr;165(4):1329-34.

PMID:
11257711
48.

ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues.

Yerushalmi N, Keppler-Hafkemeyer A, Vasmatzis G, Liu XF, Olsson P, Bera TK, Duray P, Lee B, Pastan I.

Gene. 2001 Mar 7;265(1-2):55-60.

PMID:
11255007
49.

Pigmented renal clear cell carcinoma with melanocytic differentiation.

Lei JY, Middleton LP, Guo XD, Duray PH, McWilliams G, Linehan WM, Merino MJ.

Hum Pathol. 2001 Feb;32(2):233-6.

PMID:
11230713
50.

Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma.

Lei JY, Wang Y, Jaffe ES, Turner ML, Raffeld M, Sorbara L, Morris J, Holland SM, Duray PH.

Am J Dermatopathol. 2000 Dec;22(6):524-9.

PMID:
11190445

Supplemental Content

Support Center